First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: Enova International: the setup is constructive — Quarterly loan origination volumes and net receivables growth - signals demand trends and portfolio expansion capacity
★ Analysts see FY2026 revenue reaching $3.8B — +19.8% growth in a single year.
Why Revenue Could Accelerate
1Quarterly loan origination volumes and net receivables growth - signals demand trends and portfolio expansion capacity
2Net charge-off rates and 30+ day delinquency trends - early indicators of credit quality deterioration or improvement that directly impact profitability
3Funding costs and access to capital markets - ability to securitize receivables and maintain warehouse line capacity affects growth potential and margins
4Regulatory developments in consumer lending - state-level APR caps, CFPB actions, or licensing restrictions can materially impact addressable market
5Revenue yield on loan portfolio - reflects pricing power and mix shift between higher-yielding consumer loans versus lower-yielding small business products
growth with value characteristics - The 57.6% EPS growth and 24.4% ROE attract growth investors…
Rising interest rates have mixed effects: (1) NEGATIVE impact on funding costs as warehouse lines and ABS issuance become more expensive…
Watch on earnings: Federal Funds Rate and high-yield credit spreads - directly impact funding costs and securitization execution, Unemployment rate and initial jobless claims - leading indicators of charge-off trends with 2-3 month lag, Consumer sentiment and personal savings rate - signal borrower financial stress and loan demand trends.
One Sentence Summary:
The bull case is simple: analysts see revenue climbing from $3.8B to $4.4B as quarterly loan origination volumes and net receivables growth - signals demand trends and portfolio expansion capacity.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.